A better understanding of the methylation patterns of MMR genes that can be inherited over generations and may cause familial tumorigenesis such as Lynch syndrome (25% of MSI tumors) may lead to better treatment for these women who experience a 60% lifetime risk of EC [151]. This evidence concerns the gene MRC1 and Lynch syndrome.